Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, StemCell Institute's Enterprise Value is 円5,374 Mil.
StemCell Institute's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円223 Mil. Therefore, StemCell Institute's EV-to-EBIT ratio for today is 24.07.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, StemCell Institute's Enterprise Value is 円5,374 Mil.
StemCell Institute's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円380 Mil. Therefore, StemCell Institute's EV-to-EBITDA ratio for today is 14.14.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, StemCell Institute's Enterprise Value is 円5,374 Mil.
StemCell Institute's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was 円2,811 Mil. Therefore, StemCell Institute's EV-to-Revenue ratio for today is 1.91.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
StemCell Institute (TSE:7096) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
StemCell Institute's current Enterprise Value is 円5,374 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. StemCell Institute's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円223 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
StemCell Institute's current Enterprise Value is 円5,374 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. StemCell Institute's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円380 Mil.
StemCell Institute's current Enterprise Value is 円5,374 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. StemCell Institute's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was 円2,811 Mil.
StemCell Institute's current Enterprise Value is 円5,374 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. StemCell Institute's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 円74 Mil.
StemCell Institute's current Enterprise Value is 円5,374 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. StemCell Institute's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円-453 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
StemCell Institute Enterprise Value Related Terms
StemCell Institute Enterprise Value Historical Data
* Premium members only.
The historical data trend for StemCell Institute's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7096 vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, StemCell Institute's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
StemCell Institute Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, StemCell Institute's Enterprise Value distribution charts can be found below:
* The bar in red indicates where StemCell Institute's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
StemCell Institute's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
StemCell Institute (TSE:7096) has a Enterprise Value of 円5,374 Mil as of Jul. 13, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on StemCell Institute and its competitors.
Is StemCell Institute's Enterprise Value too high?
StemCell Institute's current Enterprise Value is 円5,374 Mil. Overall, StemCell Institute has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does StemCell Institute's Enterprise Value compare to VRTX and REGN?
StemCell Institute's Enterprise Value of 円5,374 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on StemCell Institute and its competitors. StemCell Institute's current Enterprise Value is 円5,374 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemCell Institute stock overvalued right now?
Based on GuruFocus' analysis, StemCell Institute (TSE:7096) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,813.29, compared to a current price of 円768.00 — trading 57.6% below its estimated fair value. The current Enterprise Value is 円5,374 Mil. StemCell Institute's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For StemCell Institute (TSE:7096), the current Enterprise Value is 円5,374 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is StemCell Institute (TSE:7096) Overvalued in 2026?
Based on GuruFocus' analysis, StemCell Institute stock appears to be undervalued.
The current stock price of 円768.00 is trading 57.6% below its estimated GF Value™ of 円1,813.29.
GuruFocus considers StemCell Institute to be Possible Value Trap.
Key valuation signals for TSE:7096:
Enterprise Value: 円5,374 Mil
GF Value™: 円1,813.29 vs. price of 円768.00 (57.6% below fair value)
No single metric tells the full story. See the TSE:7096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
StemCell Institute is engaged in the Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects the mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood. The Company operates in a single segment, the cell bank business sales consist of three components: technical fees, storage fees, and other fees.
69GF Score
Get the complete analysis for TSE:7096
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7096 has been successfully added to your 
